Toxoplasma gondii is a globally prevalent apicomplexan parasite. Its pathogenicity depends critically on the effector protein ROP18. ROP18 functions as a serine/threonine kinase that phosphorylates and inactivates host immunity-related GTPases (IRGs), thereby enabling the parasite to evade host immune defenses and establish a successful intracellular niche. This study presents an in-silico analysis of the ROP18 protein sequence. ProtParam analysis of the 554-amino-acid protein revealed a molecular weight of 62.67 kDa and a theoretical isoelectric point (pI) of 8.96, indicating a basic character consistent with its potential for interactions with host cell components. The amino acid composition is rich in Leucine (10.5%) and Arginine (9.2%), while the calculated instability index of 42.36 classifies ROP18 as an unstable protein, which may be related to its tight regulatory control and function. The aliphatic index of 83.43 suggests relatively high thermostability, a factor in the protein's robustness within the host environment. Furthermore, we utilized the AlphaFold system to predict the high-confidence three-dimensional structure of ROP18. This model provides crucial insights into the kinase domain architecture and reveals potential active sites and surface epitopes. The elucidated 3D structure serves as a vital resource for future studies, opening avenues for structure-based design of novel interventions. Specifically, this model can be leveraged to develop inhibitory compounds that block ROP18's kinase activity, to identify immunodominant regions for improved serological diagnostics, and to inform reverse vaccinology approaches for a subunit vaccine. Ultimately, targeting this key virulence factor holds promise for new therapeutic and detection strategies against toxoplasmosis.
